ArticleHepatitis research and treatment2016

Two-Year Follow-Up Analysis of Telaprevir-Based Antiviral Triple Therapy for HCV Recurrence in Genotype 1 Infected Liver Graft Recipients as a First Step towards Modern HCV Therapy.

Fritz Klein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.